Assessing small airway impairment in mild-to-moderate smoking asthmatic patients

Eur Respir J. 2016 Apr;47(4):1264-7. doi: 10.1183/13993003.01708-2015. Epub 2016 Feb 11.

Authors

Marco Contoli¹, Federico Bellini¹, Luca Morandi¹, Giacomo Forini¹, Stefano Bianchi², Giulia Gnesini¹, Brunilda Marku¹, Klaus F Rabe³, Alberto Papi⁴

Affiliations

¹ Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy.
² Dept of Pharmacy, University Hospital of Ferrara, Ferrara, Italy.
³ LungClinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany Dept of Medicine, Christian Albrechts University Kiel, Member of the German Center for Lung Research, Kiel, Germany.
⁴ Research Centre on Asthma and COPD, Dept of Medical Sciences, University of Ferrara, Ferrara, Italy [email protected].

PMID: 26869674
DOI: 10.1183/13993003.01708-2015

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adrenal Cortex Hormones / administration & dosage
Adrenergic beta-2 Receptor Agonists / administration & dosage
Adult
Asthma / physiopathology*
Bronchi / physiopathology*
Cross-Sectional Studies
Drug Compounding
Humans
Longitudinal Studies
Middle Aged
Oscillometry
Particle Size
Reproducibility of Results
Respiratory Function Tests
Smoking*
Young Adult

Substances

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists

Associated data

ClinicalTrials.gov/NCT01620099